BioCentury
ARTICLE | Clinical News

GemRIS: Phase Ib started

August 15, 2016 7:00 AM UTC

Taris began an open-label, European Phase Ib trial to evaluate TAR-200 inserted into the bladder for 7 days at days 0 and 21 in up to 30 patients with intermediate-risk NMIBC before transurethral rese...